Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.

PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...

Merck (MRK) stock in focus as its lung disease drug Winrevair gains FDA priority review for a label update based on Phase 3 ...

Seven cases of patent ductus arteriosus with pulmonary hypertension and reversal of the usual direction of flow are described. Breathing of a low oxygen mixture either initiated or increased the ...

Merck MRK announced that the phase III HYPERION study evaluating its pulmonary arterial hypertension (“PAH”) drug, Winrevair ...

If the diameter was >2 mm, the Qp:Qs was usually more than 2:1 (ie, twice as much pulmonary blood flow as systemic). The other measure that relates well to Qp:Qs is the pattern of diastolic flow ...

Pulmonary hypertension (PH) is now defined as mean pulmonary artery pressure >20 mm Hg according to the updated clinical classification from the 6th World Symposium of Pulmonary Hypertension (WSPH) ...

Group 4: CTEPH (chronic thromboembolic pulmonary hypertension)—In some patients, pulmonary embolism, or blood clots, in the lung’s arteries can form scar-like tissue, blocking or narrowing the ...

If you are diagnosed with pulmonary hypertension (PH) or your doctor suspects PH, it is important for you to see a specialist. Pulmonary arterial hypertension (PAH) is a rare, progressive lung disease ...

BMPER overexpression mitigated the vascular remodeling that characterizes pulmonary arterial hypertension (PAH), according to a preclinical study published in Cellular Signalling. In vivo and in ...

Other causes of PAA include pulmonary hypertension, vasculitis, syphilis, tuberculosis, left-to-right shunts, pulmonary valve stenosis with post-stenotic dilatation, vasa vasorum dysfunction, trauma, ...